Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Natura:	Articolo
Lingua:	Russian
Pubblicazione:	«REMEDIUM GROUP» Ltd. 2023-01-01
Serie:	Атеротромбоз
Soggetti:	active cancer multifocal atherosclerosis d-dimer gdf-15 vegf-a prognosis determining outcomes
Accesso online:	https://www.aterotromboz.ru/jour/article/view/287

Documenti analoghi

GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register
di: Elena N. Krivosheeva, et al.
Pubblicazione: (2024-07-01)

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention
di: E. N. Krivosheeva, et al.
Pubblicazione: (2021-08-01)

Serum Concentration of Growth Differentiation Factor 15 and Atherosclerosis among General Older Japanese Individuals with Normal Weight
di: Yuji Shimizu, et al.
Pubblicazione: (2023-05-01)

Assessment of the Anticancer Effects of Simvastatin on Human Osteosarcoma and Colorectal Cancer Cell Lines
di: Sarah Mazin Naeem, et al.
Pubblicazione: (2024-12-01)

Relationship between lipid profile parameters, coagulation system and inflammation markers in patients with hypertension and multifocal atherosclerosis
di: S. S. Vedenskaya, et al.
Pubblicazione: (2024-12-01)

Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV
di: Léna Royston, et al.
Pubblicazione: (2022-08-01)

Interrelation of growth/differentiation factor-15 level with laboratory and clinical and functional parameters of patients with coronary artery disease
di: E. A. Zakharyan
Pubblicazione: (2023-06-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
di: V. V. Genkel, et al.
Pubblicazione: (2021-03-01)

Determinants of growth differentiation factor 15 plasma levels in outpatients with peripheral arterial disease
di: Emma Skau, et al.
Pubblicazione: (2024-12-01)

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study
di: Lena Mathews, et al.
Pubblicazione: (2023-03-01)

Diagnosis of multifocal atherosclerosis in low-to moderate-risk patients and their restratification
di: O. V. Fatenkov, et al.
Pubblicazione: (2020-11-01)

Features of atherosclerosis in carotid and coronary arteries
di: E. V. Konstantinova, et al.
Pubblicazione: (2021-10-01)

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
di: Olga O. Shakhmatova, et al.
Pubblicazione: (2023-11-01)

Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese
di: Shuai Zheng, et al.
Pubblicazione: (2023-04-01)

Diagnostic and prognostic significance of D-dimer in internal medicine
di: Yu A Fedotkina, et al.
Pubblicazione: (2003-12-01)

GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia
di: Alaa Efat, et al.
Pubblicazione: (2022-05-01)

The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis
di: Mousa Khalafi, et al.
Pubblicazione: (2023-08-01)

The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis
di: Mousa Khalafi, et al.
Pubblicazione: (2023-08-01)

Clinical and prognostic importance of assessment of interleukin-12 blood concentration in patients with multifocal atherosclerosis after carotid endarterectomy
di: A. V. Frolov, et al.
Pubblicazione: (2014-06-01)

Strategy for endovascular treatment of a patient with combined coronary and carotid artery atherosclerosis: a case report
di: F. B. Shukurov, et al.
Pubblicazione: (2023-01-01)

Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
di: O L Barbarash, et al.
Pubblicazione: (2019-12-01)

Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
di: S A Gracheva, et al.
Pubblicazione: (2014-10-01)

Association between Serum GDF-15 and Cognitive Dysfunction in Hemodialysis Patients
di: Hae Ri Kim, et al.
Pubblicazione: (2024-02-01)

Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model
di: Bina Albuquerque, et al.
Pubblicazione: (2022-03-01)

Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia
di: Jingru Cheng, et al.
Pubblicazione: (2023-03-01)

Role of GDF-15 as an inflammatory marker in patients with psoriasis vulgaris
di: Mustafa Kaan Taşolar, et al.
Pubblicazione: (2021-12-01)

Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity
di: Mohamed Asrih, et al.
Pubblicazione: (2022-07-01)

Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
di: V V Genkel, et al.
Pubblicazione: (2019-10-01)

RELATIONSHIP OF MULTIFOCAL ATHEROSCLEROSIS AND RENAL DYSFUNCTION WITH IN-HOSPITAL COMPLICATIONS AFTER CORONARY BYPASS OPERATION IN ISCHEMIC HEART DISEASE
di: K. S. Shafranskaya, et al.
Pubblicazione: (2015-03-01)

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?
di: O. L. Barbarash, et al.
Pubblicazione: (2020-09-01)

Markers of hemostasis activation and endothelial damage in patients with active cancer
di: A. B. Dobrovolsky, et al.
Pubblicazione: (2022-06-01)

A patient with сoronary artery disease and multifocal atherosclerosis. How to optimize the prognosis?
di: O. L. Barbarash, et al.
Pubblicazione: (2018-09-01)

Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM
di: Jesús Cadenas, et al.
Pubblicazione: (2022-08-01)

The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients
di: Elena A. Klesareva, et al.
Pubblicazione: (2022-05-01)

Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
di: Christopher R. deFilippi, et al.
Pubblicazione: (2023-02-01)

Increased Growth Differentiation Factor 15 Levels Are Associated with HIV-Associated Neurocognitive Impairment: A Pilot Study
di: Ali Boustani, et al.
Pubblicazione: (2025-01-01)

SHORT-TERM RESULTS OF CARDIOSYNCHRONIZED CONSEQUENTIAL ANTEGRADE PNEUMOCOMPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
di: O. U. Atkov, et al.
Pubblicazione: (2015-03-01)

Maternal levels of growth differentiation factor-15 in patients with preeclampsia
di: Ilkbal Temel Yuksel, et al.
Pubblicazione: (2018-10-01)

Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients
di: Heba M. Adel Abou Zaghla, et al.
Pubblicazione: (2021-01-01)

SURGICAL TREATMENT OF MULTIFOCAL ATHEROSCLEROSIS: CORONARY AND BRACHIOCEPHALIC PATHOLOGY AND PREDICTORS OF EARLY ADVERSE EVENTS DEVELOPMENT
di: R. S. Tarasov, et al.
Pubblicazione: (2017-08-01)